logo-altasciences

EN - Main navigation

  • Proactive Drug Development
  • Solutions
  • Compare Us
  • Facilities
  • About Us
  • Resource Center
  • Careers
  • News & Events
  • Contact Us
  • Participate in a study
Français
  • Home
  • Current: Highly Potent API (HPAPI) Handling

Highly Potent API (HPAPI) Handling

Share this page

Oncology research, cancer treatments, and other targeted therapies, have made highly potent active pharmaceutical ingredients (HPAPIs) a rapidly growing segment in the pharmaceutical industry worldwide. There are currently thousands of HPAPIs in development that promise lower dose requirements and/or fewer side effects. Handling of these compounds requires expertise and specialized equipment to take them from formulation to manufacturing for clinical supply and eventually, to market.

Our Expertise

We have decades of experience formulating, developing, and manufacturing drug products containing HPAPIs, within our facility’s high-potency/Grade C and D manufacturing and handling areas. Our highly trained experts have handled countless projects, including analytical testing and method development, qualification, and validation. We provide cost-effective process scale-up for your projects, from prototype formulations to commercial scale batches, using a range of formulation techniques and dosage forms, including microparticle formulations and nanomilling.

QUICK CHAT ― This short video provides a quick overview of our solutions for highly potent compounds (HPAPIs), including the seamless shipping and handling of controlled substances.

 

API Classification

New APIs undergo robust evaluation to determine their classification level for safe handling procedures and clearance limits. Performance-based exposure control limit (PB-ECL) is then used to correctly classify the compound (Class 1 to Class 4).

Highly potent API handling - Potent Coumpound Classification

cGMP Facility

Our 64,000-square-foot cGMP facility is designed and equipped to meet the challenges associated with the complex handling of HPAPIs and other controlled substances with high toxicity levels, including: 

  • Dedicated high-potency/Grade C and D manufacturing and handling areas
  • Registrations and licenses: FDA drug establishment registration, manufacturer DEA license (Schedules I-V and List 1), FDA food facility registration
  • State-of-the-art equipment used for HPAPI handling and manufacturing , including:
    • Kettles
    • Mills
    • Peristalic pumps
    • Heater/chillers
    • Vibroscreens
    • Vial crimpers

We have strict safety and security processes in place for the containment of potent compounds to minimize risk of exposure, and ensure our facility and personnel are adequately protected at all times:

  • Stringent safety and cleaning protocols for HPAPI containment, with 100% analytical verification for room clearances
  • Total enclosure processes to reduce employee exposure
  • Rooms designed with one-way traffic flow to minimize and/or eliminate compound transfer
  • Personal protective equipment (PPE), as well as respirators or powered air-purified respirators (PAPRs) 
  • Engineering controls for potent compound control, including:
    • HEPA filters for superior air filtration
    • Magnehelic® gauges
    • Rees building monitoring system

High-Potency Manufacturing SolutionsPODCAST ― Altasciences’ experts present our potent handling capabilities, including a general overview of our facility and services, processes, equipment, and compound classifications.

Have a highly potent API that needs to be developed? We are up for the challenge! Send us a message.

 

Explore All our Manufacturing and Analytical Solutions.

Explore

Sign up for exclusive content

Join our list of 30,000+ VIP members and have access to our exclusive content.

Stay connected

  • linkedin
  • youtube

Footer

    • Solutions

      • Preclinical Services
      • Clinical Services
      • Manufacturing and Analytical Services
      • Bioanalytical Services
      • Research Support Services
      • Development Programs
    • News & Events

      • Altasciences Events
      • Press Releases
      • Altasciences in the News
      • Press Kit
    • Resource Center

      • The Altascientist
      • Webinars/Podcasts
      • Newsletters
      • Scientific Publications
      • Blog
      • Videos
    • Study Types

      • Preclinical
      • Lead Optimization
      • Pharmacology
      • Pharmacokinetics/​Pharmacodynamics
      • Acute Toxicology
      • Dose Range Finding​/​Maximum Tolerated Dose
      • Repeated Dose Toxicity
      • Safety Pharmacology
      • Sub-Chronic/Chronic, Repeated Dose Toxicity
      • Clinical
      • First in Human
      • Proof of Concept
      • Bioavailability/Bioequivalence
      • Pharmacokinetics in Special Populations
      • Human Abuse Potential
      • Driving Simulation
      • Drug-Drug Interaction
      • QT Assessment
      • Renal and Hepatic Impaired
      • Imaging
      • Biologics​/​Biosimilars
    • Therapeutic Areas

      • Cardiology
      • Dermatology
      • Gastroenterology
      • Hematology
      • Immunology
      • Infectious Diseases
      • Metabolism and Endocrinology
      • Neurology
      • Oncology
      • Ophthalmology
      • Orthopedics
      • Psychiatry
      • Respirology
      • Rheumatology
      • Substance Abuse
      • Urology
      • Women’s Health
    • About us

      • History
      • Our Origins
      • Awards
      • Testimonials
    • Careers

    • Contact Us

    • Locations

    • Stay connected

      • Facebook
      • Youtube

2025 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy

Have a question?

I'd be happy to help.

Captcha is required.